Assetmark, Inc Amicus Therapeutics, Inc. Transaction History
Assetmark, Inc
- $32.1 Billion
- Q2 2024
A detailed history of Assetmark, Inc transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Assetmark, Inc holds 159,868 shares of FOLD stock, worth $1.71 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
159,868
Previous 117,807
35.7%
Holding current value
$1.71 Million
Previous $1.39 Million
14.28%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding FOLD
# of Institutions
278Shares Held
324MCall Options Held
260KPut Options Held
261K-
Vanguard Group Inc Valley Forge, PA28.6MShares$306 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY28.1MShares$300 Million8.05% of portfolio
-
Avoro Capital Advisors LLC New York, NY27.4MShares$293 Million3.71% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$261 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA21.1MShares$226 Million0.04% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $3B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...